David Neafus is a highly experienced financial and operating executive with an impressive track record of success. He specializes in startups, turnarounds, IPO's, M&A, debt financing, and equity financing. Over the past several years, David has worked with over 75 companies, serving as CFO and financial advisor, and has a staff of finance and HR professionals that assist him in the total outsourcing of the finance and HR functions. He has substantial experience working with boards of directors and has worked in BioTech, HighTech, CleanTech, Manufacturing, distribution, and other industries. David holds a BS in Accounting from the University of MN and has studied an MBA in Finance at Bentley.

Some of the companies he has worked with include Qlaris Bio, Makana Therapeutics, Vestigen, Nayan Therapeutics, Verve Therapeutics, Abcuro, Origin Biosciences, Phoenix Tissue Repair, InVitroMetrix, Panther Pharmaceuticals, Rest Devices, Combined Therapeutics, Amathus Therapeutics, Arrakis Therapeutics, IFM Therapeutics, SDX Partners, SynDevRx, Be the Partner, KDAC Therapeutics, Zippity Cars, Relavor BioPharmacuetical Labs, Q-State Biosciences, Revitope, Twine Health, Boston Electro Metallurgical Corporation, Obsidian Therapeutics, Obsidio Therapeutics, GlyTR Therapeutics, Tiger Therapeutics, OXT Therapeutics, Ixcela, Icelandic Provisions, STEAMM Catalyst, MSDC, Keratin Biosciences, Altaeros Energies, Coffee Refined Genetics, Norwich Technologies, Synlogic, Avaxia Biologics, Avastus Preclinical, Surface Oncology, Tri-Institutional Therapeutics Discovery Institute, O&R Patent law, Teleos Therapeutics, Padlock Therapeutics, Intrinsic Therapeutics, Tetragenetics, Geneius, IlluminOss Medical Inc., Wingu, Daktari Diagnostics, Via Sciences (Formerly Gene Network Sciences), Broad Institute of MIT and Harvard, Foundation Medicine, Afferent Pharmaceuticals, Edimer Pharmaceuticals, Neurophage Pharmaceuticals, Galenea, Stromedix, SustainX, IVREA Pharmaceuticals, BioAssets Development, GlycoFi, InnovaSage, Link Medicine Corporation, Vitae Pharmaceuticals, Hydra Biosciences, Inc., Alnylam Pharmaceuticals, Inc., IPM, Heartware (formerly Kriton Medical), and Infinity Pharmaceuticals, Inc.

David Neafus is known for his excellent financial and operational skills, and his ability to deliver results. He has a broad range of expertise, and his experience in various industries makes him a valuable asset to any company. He has a reputation for being a reliable and effective CFO and financial advisor, and he is highly respected in his field.